AMICULUM Consulting Blog | Strategic planning
What can pharma learn from the renaissance in British cycling?
In the aftermath of the great 2012 Olympics in London and Chris Froome’s commanding Tour de France victory in 2013 I have been struck by a couple of reports and interviews around the success of British cycling that might have implications in our sector
Brainstorm, brainshower, or no-brainer?
It’s 11 o’clock on Tuesday morning and Max has just walked out of a 3-hour meeting with the head guys from ‘global’ about the strategy for their new anti-hypertensive medicine Cardiofix. Cardiofix was supposed to be a blockbuster, but the global market access strategy is not working. Uptake at specialist centres in Europe is variable and primary care doctors don’t seem to be prescribing Cardiofix.